Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Abstract
Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes. Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals, were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass. However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin, raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance. Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We discuss how pathways that “sense” nutrients within skeletal muscle are readily able to regulate insulin action.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“The mTOR/ p70S6 kinase pathway is a putative nutrient-sensing pathway, and overactivation of this pathway in cell-based systems, rodents, and humans is also associated with insulin resistance (37)(38)(39).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [37]
In the citing paper
“Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153].”
From AMPK and Exercise: Glucose Uptake and Insulin Sensitivity (2013) · cites this paper as [151]
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“To test this further, two genetic models of obesity were examined: K/K A y and ob/ob mic”
MethodMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“gif" NDATA ITEM> ]> Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabete”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Protein extracts from tissue samples were analysed as describe”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“As increased circulating FFAs are implicated in insulin resistanc”
BackgroundHara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 4×
“a, S6K1 Thr 389 and S6 Ser 240/244 phosphorylation in fat of wild-type mice maintained on a NCD (2) or HFD (þ) for 4 months.”
BackgroundMethodInfluential
Cited by
Items 301–400 of 1,004
mTOR signaling in tumorigenesis
Xu, K., Liu, P., & Wei, W. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.007 · Cited by 165
eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies
Alain, T., Morita, M., Fonseca, B. D., Yanagiya, A., Siddiqui, N., Bhat, M., Zammit, D., Marcus, V., Metrakos, P., Voyer, L.-A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2395 · Cited by 157
White, M. F. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-008 · Cited by 163
Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients
Kasiske, B. L., de Mattos, A., Flechner, S. M., Gallon, L., Meier-Kriesche, H.-U., Weir, M. R., & Wilkinson, A. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02272.x · Cited by 163
“Animal models have shown an increase in free fatty acid levels with disruption of the mTOR pathway (25).”
BackgroundMuscular diacylglycerol metabolism and insulin resistance
Timmers, S., Schrauwen, P., & de Vogel, J. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.12.002 · Cited by 161
A comparative perspective on lipid storage in animals
Birsoy, K., Festuccia, W. T., & Laplante, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.104992 · Cited by 157
“The increase in J o u rn a l o f C e ll S c ie n c e adiposity found upon high-fat feeding, leptin deficiency or pharmacological PPARc activation is associated with a marked activation of mTORC1 in adipose tissue (Um et al., 2004; Blanchard et al., 2012).”
BackgroundDixit, V. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108028 · Cited by 158
“A recent study found that influenza virus infection in diet-induced obese (DIO) mice causes impaired immune response with a sixfold increased mortality as a result of infection [15].”
BackgroundInfluentialHypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes
Brown, N. F., Stefanović-Račić, M., SIPULA, I. J., & Perdomo, G. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.016 · Cited by 174
“Nevertheless, the increased rate of fatty acid oxidation we observed in hepatocytes is in agreement with the enhanced fatty acid use seen in the p70S6K −/−mice and Drosophila mutant dTOR [30,32]; and it seems likely that a common mechanism (involving mTOR in conjunction with p70S6K) acts to mediate that particular eff…”
BackgroundResultInfluentialOng, P. S., Wang, L. Z., Dai, X., Tseng, S. H., Loo, S. J., & Sethi, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00395 · Cited by 162
“The sustained feedback via the mTORC1/S6K1 route has been confirmed by many others as a single most important mechanism for inducing IR (Tremblay and Marette, 2001; Harrington et al., 2004; Shah et al., 2004; Um et al., 2004; Nyman et al., 2014).”
BackgroundRictor is a novel target of p70 S6 kinase-1
Treins, C., Warne, P. H., Magnuson, M. A., Pende, M., & Downward, J. (2009) · Oncogene · doi:10.1038/onc.2009.401 · Cited by 175
“, 2009) and S6K1 plays a central role under nutritional conditions in which mTOR is chronically activated, such as high-fat diet (Um et al., 2004).”
BackgroundLoss of mTORC1 signalling impairs β-cell homeostasis and insulin processing
Blandino-Rosano, M., Barbaresso, R., Jimenez-Palomares, M., Bozadjieva, N., Werneck-de-Castro, J. P., Hatanaka, M., Mirmira, R. G., Sonenberg, N., Liu, M., Rüegg, M. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms16014 · Cited by 161
Ge, Y., Wu, A.-L., Warnes, C., Liu, J., Zhang, C., Kawasome, H., Terada, N., Boppart, M. D., Schoenherr, C. J., & Chen, J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00248.2009 · Cited by 152
“Previously reported embryonic stem cells with targeted deletion of s6k1 (22) were used to generate systemic knockout animals, which were viable and fertile but smaller in size (data not shown), consistent with the report by Thomas and colleagues (38).”
Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
Armour, S. M., Baur, J. A., Hsieh, S. N., Land-Bracha, A., Thomas, S. M., & Sinclair, D. A. (2009) · Aging · doi:10.18632/aging.100056 · Cited by 156
“Of considerable interest is the fact that resveratroltreated mice exhibit most of the phenotypes of S6K1-/mice when fed a high fat diet [12, 13, 42].”
BackgroundFonseca, B. D., Diering, G. H., Bidinosti, M. A., Dalal, K., Alain, T., Balgi, A. D., Forestieri, R., Nodwell, M., Rajadurai, C. V., Gunaratnam, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359638 · Cited by 159
Goberdhan, D. C. I., Meredith, D., Boyd, C. A. R., & Wilson, C. (2005) · Development · doi:10.1242/dev.01821 · Cited by 151
“Currently, the feedback mechanism involved has not been fully elucidated, although studies in mammals, where a similar phenomenon occurs, suggest that the phosphorylation state of IRS-1, an adaptor molecule for the InR, is involved (Jaeschke et al., 2002; Um et al., 2004; Harrington et al., 2005).”
BackgroundThe evolution of the TOR pathway and its role in cancer
Beauchamp, E. M., & Platanias, L. C. (2012) · Oncogene · doi:10.1038/onc.2012.567 · Cited by 174
The Late Endosome is Essential for mTORC1 Signaling
Flinn, R. J., Yan, Y., Goswami, S., Parker, P. J., & Backer, J. M. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-09-0756 · Cited by 158
Pedroso, J. A. B., Zampieri, T. T., & Donato, J. (2015) · Nutrients · doi:10.3390/nu7053914 · Cited by 172
“This effect is relevant to inducing insulin resistance in situations of nutrient abundance such as in obesity [14,15].”
BackgroundZhu, M. J., Han, B., Tong, J., Ma, C., Kimzey, J. M., Underwood, K. R., Xiao, Y., Hess, B. W., Ford, S. P., Nathanielsz, P. W., et al. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149633 · Cited by 154
“Since activated mTOR phosphorylates IRS-1 at Ser 636/639, which negatively affects IRS-1 function and down-regulates insulin signalling (Um et al. 2004; Khamzina et al. 2005), the down-regulation of AMPK should activate mTOR, which de-sensitizes insulin signalling.”
BackgroundThe two faces of reactive oxygen species (ROS) in adipocyte function and dysfunction
Castro, J. P., Grune, T., & Speckmann, B. (2016) · Biological Chemistry · doi:10.1515/hsz-2015-0305 · Cited by 165
Kim, J.-H., Kim, J. E., Liu, H.-Y., Cao, W., & Chen, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708568200 · Cited by 154
Das, A., Durrant, D., Koka, S., Salloum, F. N., Xi, L., & Kukreja, R. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521062 · Cited by 153
“A persistent activation of mTORC1 signaling occurs in both genetic and diet-induced animal models of obesity and metabolic disorders in liver (14), skeletal muscle (14, 15), adipose tissue (16, 17), and heart (18, 19).”
p62/SQSTM1 at the interface of aging, autophagy, and disease
Bitto, A., Lerner, C. A., Nacarelli, T., Crowe, E. P., Torres, C. A., & Sell, C. (2014) · AGE · doi:10.1007/s11357-014-9626-3 · Cited by 168
“…of S6K1, a mTORC1 substrate, can trigger a negative feedback on the insulin receptor substrate 1 (IRS-1), thereby impairing insulin signaling (Um et al. 2004). mTORC1 response to insulin is independent of p62/ SQSTM1 (Duran et al. 2011) and the insulin signaling pathway is not impaired in…”
The Complexes of Mammalian Target of Rapamycin
Zhou, H., & Huang, S. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310791824093 · Cited by 145
PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Bezy, O., Tran, T. T., Pihlajamäki, J., Suzuki, R., Emanuelli, B., Winnay, J., Mori, M. A., Haas, J., Biddinger, S. B., Leitges, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46045 · Cited by 147
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Cornu, M., Oppliger, W., Albert, V., Robitaille, A. M., Trapani, F., Quagliata, L., Fuhrer, T., Sauer, U., Terracciano, L., & Hall, M. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412047111 · Cited by 152
AMPK exerts dual regulatory effects on the PI3K pathway
Tao, R., Gong, J., Luo, X., Zang, M., Guo, W., Wen, R., & Luo, Z. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-1 · Cited by 141
“Likewise, deletion of S6K1 alleles increases insulin sensitivity and protects mice against age- and diet-induced obesity [32].”
BackgroundRecent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects
Cai, H., Dong, L., & Liu, F. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.011 · Cited by 162
“In mice, knockout of the mTORC1 downstream effectors, 4E-BP1 and 4E-BP2, decreased lipolysis, while deleting S6K greatly increased lipolysis [74].”
BackgroundmTORC1 signaling: what we still don't know
Wang, X., & Proud, C. G. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq038 · Cited by 144
“Also potentially relevant for human health, S6Ks can negatively regulate insulin signaling through the phosphorylation of insulin receptor substrate 1 (IRS1) and which impairs PI3K/Akt signaling downstream of the insulin receptor (Harrington et al., 2004; Um et al., 2004; Shah and Hunter, 2006), although there is disa…”
BackgroundAn anti-aging drug today: from senescence-promoting genes to anti-aging pill
Blagosklonny, M. V. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.004 · Cited by 172
Martin, K. A., Merenick, B. L., Ding, M., Fetalvero, K. M., Rzucidlo, E. M., Kozul, C. D., Brown, D. J., Chiu, H. Y., Shyu, M., Drapeau, B. L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703914200 · Cited by 146
mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis
Laplante, M., & Sabatini, D. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000323107 · Cited by 145
“Interestingly, mTORC1 activation promotes insulin resistance by inducing a negative feedback loop in which S6K phosphorylates IRS and reduces its stability (18).”
BackgroundResultRapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
Chang, G.-R., Chiu, Y.-S., Wu, Y.-Y., Chen, W.-Y., Liao, J.-W., Chao, T.-H., & Mao, F. C. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08215fp · Cited by 147
New insights into insulin resistance in the diabetic heart
Gray, S., & Kim, J. K. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.001 · Cited by 165
Targeting Mnks for Cancer Therapy
Hou, J., Lam, F., Proud, C., & Wang, S. (2012) · Oncotarget · doi:10.18632/oncotarget.453 · Cited by 142
“Its loss results in activation of Akt and increases downstream mTORC1 signalling.”
BackgroundInfluentialYin, Y., Hua, H. M., Li, M., Liu, S., Kong, Q., Shao, T., Wang, J., Luo, Y., Wang, Q., Luo, T. L., et al. (2015) · Cell Research · doi:10.1038/cr.2015.133 · Cited by 157
Feedback on Fat: p62-mTORC1-Autophagy Connections
Moscat, J., & Diaz-Meco, M. T. (2011) · Cell · doi:10.1016/j.cell.2011.10.021 · Cited by 140
“Although these results agree with previous data demonstrating that loss of the mTORC1 target S6K1 results in an obesity-resistant phenotype (Um et al., 2004), they are at odds with mTORC1 negatively regulating autophagy and promoting adipogenesis and adiposity in vivo (Zhang et al., 2009).”
BackgroundResultRemoval of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity
Antion, M. D., Merhav, M., Hoeffer, C. A., Reis, G., Kozma, S. C., Thomas, G., Schuman, E. M., Rosenblum, K., & Klann, E. (2008) · Learning & Memory · doi:10.1101/lm.661908 · Cited by 138
“This finding is in line with the observation that S6K1-deficient mice are protected from aging-and diet-associated obesity due to the loss of a negative feedback loop extended from S6K1 to the insulin receptor substrate 1 (IRS1) (Um et al. 2004).”
Self-citationTargeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
Cheng, H., Shcherba, M., Pendurti, G., Liang, Y., Piperdi, B., & Perez-Soler, R. (2014) · Lung Cancer Management · doi:10.2217/lmt.13.72 · Cited by 156
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Conciatori, F., Ciuffreda, L., Bazzichetto, C., Falcone, I., Pilotto, S., Bria, E., Cognetti, F., & Milella, M. (2018) · Cancers · doi:10.3390/cancers10010023 · Cited by 141
“mTORC2 pathway is regulated also by mTORC1, through negative feedback loop between mTORC1 and insulin/PI3K signaling, as demonstrated by some evidence which shows that p70S6K1 promotes the proteasomal degradation of Insulin Receptor Substrate (IRS) 1/2, thus downregulating PI3K/AKT pathway and mTORC2 [70].”
BackgroundDoi, M., Yamaoka, I., Nakayama, M., Sugahara, K., & Yoshizawa, F. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00609.2006 · Cited by 140
Jurczak, M. J., Lee, A.-H., Jornayvaz, F. R., Lee, H.-Y., Birkenfeld, A. L., Guigni, B. A., Kahn, M., Samuel, V. T., Glimcher, L. H., & Shulman, G. I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316760 · Cited by 143
“However, IRS1 serine phosphorylation increases with insulin stimulation (39, 52), and IRS1 serine 307 to alanine mutant knock-in mice are not protected from high-fat diet-induced insulin resistance but are paradoxically more susceptible (39).”
BackgroundmTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 138
Akt activation: A potential strategy to ameliorate insulin resistance
Zhang, Z., Liu, H., & Liu, J. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.004 · Cited by 155
Amino Acid Sensing in Metabolic Homeostasis and Health
Hu, X., & Guo, F. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa026 · Cited by 150
Validation of anti-aging drugs by treating age-related diseases
Blagosklonny, M. V. (2009) · Aging · doi:10.18632/aging.100034 · Cited by 140
“Based on preclinical data, rapamycin has been considered in such pathologies as obesity [58], atherosclerosis [53-55], cardiac hypertrophy [59-64], aortic aneurysm [65], osteoporosis [66-68], organ fibrosis ( liver, renal, cardiac fibrosis) [64, 69, 70-75], neurodegeneration [76, 77], Alzheimer's disease [78, 79], Par…”
BackgroundBachar, E., Ariav, Y., Ketzinel-Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004954 · Cited by 139
“Several studies suggested that nutrient overload leads to mTORC1 activation, thereby increasing insulin resistance [46,47].”
Leucine signaling in the pathogenesis of type 2 diabetes and obesity
Melnik, B. C. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i3.38 · Cited by 140
Impacts of essential amino acids on energy balance
Xiao, F., & Guo, F. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101393 · Cited by 127
“The mTOR pathway is elevated in many organs of obese animal models, whereas the absence of S6K1 protects against dietinduced obesity [70].”
BackgroundTzatsos, A., & Tsichlis, P. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610101200 · Cited by 140
Metabolomics in diabetes research
Friedrich, N. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0120 · Cited by 132
The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease
Shanware, N. P., Bray, K., & Abraham, R. T. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134717 · Cited by 130
AKT Signaling in Physiology and Disease
Vasudevan, K. M., & Garraway, L. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_66 · Cited by 152
A longer and healthier life with TOR down-regulation: genetics and drugs
Bjedov, I., & Partridge, L. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390460 · Cited by 128
Blanchard, P.-G., Festuccia, W. T., Houde, V. P., St-Pierre, P., Brûlé, S., Turcotte, V., Côté, M., Bellmann, K., Marette, A., & Deshaies, Y. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m021485 · Cited by 129
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira, M. N. N., Lima-Filho, R. A. S., & De Felice, F. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 132
Mir, S. U. R., George, N. M., Zahoor, L., Harms, R. Z., Guinn, Z. P., & Sarvetnick, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.605345 · Cited by 142
“However, recent studies have linked mTORC1 hyperactivation to insulin resistance and endoplasmic reticulum (ER) stress development resulting in decline in both -cell mass and function (17, 18).”
BackgroundThe mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2
Yang, X., Yang, C., Farberman, A., Rideout, T. C., de Lange, C. F. M., France, J., & Fan, M. Z. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0567 · Cited by 128
Phosphoinositide 3-kinases as a common platform for multi-hormone signaling
Hirsch, E., Costa, C., & Ciraolo, E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0097 · Cited by 151
“TORC1 in turn phosphorylates and triggers S6K, a key regulator of S6 ribosomal protein, as well as other elements necessary for the initiation of mRNA translation such as eukaryotic initiation factor 4B (eIF4B), programmed cell death protein 4 (PDCD4), and eEF2K.”
BackgroundInfluentialNatural compounds with anti-ageing activity
Argyropoulou, A., Aligiannis, N., Trougakos, I. P., & Skaltsounis, A. (2013) · Natural Product Reports · doi:10.1039/c3np70031c · Cited by 135
Young, J. E., Martinez, R. A., & La Spada, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806088200 · Cited by 129
PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation
Hahn, K., Miranda, M., Francis, V. A., Vendrell, J., Zorzano, A., & Teleman, A. A. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.015 · Cited by 131
“, 2007), and plays an important role in the regulation of organismal metabolism (Um et al., 2004).”
BackgroundChapter 3 Ribosomal Protein S6 Kinase
Meyuhas, O., & Dreazen, A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90003-5 · Cited by 150
Johansson, G., Mahller, Y. Y., Collins, M. H., Kim, M., Nobukuni, T., Perentesis, J. P., Cripe, T. P., Lane, H. A., Kozma, S. C., Thomas, G., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2335 · Cited by 147
“that whereas S6K1 drives protein synthesis downstream, it also acts in a feedback loop to temper AKT activation (23, 24).”
BackgroundSelf-citationIn vivo self-assembled small RNAs as a new generation of RNAi therapeutics
Fu, Z., Zhang, X., Zhou, X., Ur-Rehman, U., Yu, M., Liang, H., Guo, H., Guo, X., Kong, Y., Su, Y., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00491-z · Cited by 126
The rapid activation of protein synthesis by growth hormone requires signaling through mTOR
Hayashi, A. A., & Proud, C. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00674.2006 · Cited by 127
“This likely reflects inhibition by rapamycin of the negative feedback loop whereby S6K1 phosphorylates IRS1 and impairs signaling through it (25, 47).”
BackgroundMaternal cholestasis during pregnancy programs metabolic disease in offspring
Papacleovoulou, G., Abu‐Hayyeh, S., Nikolopoulou, E., Briz, Ó., Owen, B. M., Nikolova, V., Ovadia, C., Huang, X. B., Vääräsmäki, M., Baumann, M. U., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68927 · Cited by 143
“Accordingly, increased vacuolization and lipid droplets (Figure 1C), as well as reduced AMPK-α and increased mTOR phosphorylation (Figure 1D) were observed in their livers, consistent with a hepatosteatotic phenotype (25, 26).”
Zhang, L., Ussher, J. R., Oka, T., Cadete, V. J. J., Wagg, C., & Lopaschuk, G. D. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq266 · Cited by 129
Collins, S., Yehuda‐Shnaidman, E., & Wang, H. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.180 · Cited by 150
Hwahng, S. H., Ki, S. H., Bae, E. J., Kim, H. E., & Kim, S. G. (2009) · Hepatology · doi:10.1002/hep.22887 · Cited by 123
EPRS is a critical mTORC1–S6K1 effector that influences adiposity in mice
Arif, A., Terenzi, F., Potdar, A. A., Jia, J., Sacks, J., China, A., Halawani, D., Vasu, K., Li, X., Brown, J. M., et al. (2017) · Nature · doi:10.1038/nature21380 · Cited by 128
Self-citationSoares, H. P., Ni, Y., Kisfalvi, K., Sinnett‐Smith, J. W., & Rozengurt, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057289 · Cited by 136
Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination
Papaconstantinou, J. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.025 · Cited by 122
“These phosphorylations occur at Ser302, er307, Ser612 and Ser632 (Furukawa et al., 2005; Hirosumi et al., 002; Kim et al., 2004; Um et al., 2004; Yu et al., 2002).”
BackgroundThinking globally and acting locally with TOR
Arsham, A. M., & Neufeld, T. P. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.09.005 · Cited by 152
Clinical problems caused by obesity
Kyrou, I., Randeva, H., Barber, T., Tsigos, C., Kaltsas, G. A., & Weickert, M. O. (2022) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33841351 · Cited by 127
Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity
Tsai, S., Sitzmann, J. M., Dastidar, S. G., Rodriguez, A. A., Vu, S. L., McDonald, C. E., Academia, E. C., O’Leary, M. N., Ashe, T. D., La Spada, A. R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77361 · Cited by 126
“We performed our 4E-BP1 studies in transgenic mouse lines on the C57BL/6J background, as in previously published studies of genetically modified Rptor or S6k1–/– mice and in the rapamycin studies (5, 10, 11, 17, 68) to permit a direct comparison of metabolic phenotypes.”
MethodBalcazar, N., Sathyamurthy, A., Elghazi, L., Gould, A., Weiss, A., Shiojima, I., Walsh, K., & Bernal-Mizrachi, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807458200 · Cited by 127
Kim, J.-A., Jang, H.-J., Martinez-Lemus, L. A., & Sowers, J. R. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00497.2011 · Cited by 127
“Therefore, we next examined whether ANG II promoted the phosphorylation of IRS-1 at Ser, one of the well-known target sites for mTOR/p70S6K (47, 53).”
BackgroundInfluentialMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125
Kaneko, K., Ueki, K., Takahashi, N., Hashimoto, S., Okamoto, M., Awazawa, M., Okazaki, Y., Ohsugi, M., Inabe, K., Umehara, T., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.005 · Cited by 123
“Abrogation of this signal may enhance tyrosine phosphorylation of IRS proteins and reduce serine phosphorylation of Raf, ultimately increasing the signaling to the Raf/Erk pathway.”
BackgroundPancreatic β-Cell Failure Mediated by mTORC1 Hyperactivity and Autophagic Impairment
Bartolomé, A., Kimura-Koyanagi, M., Asahara, S., Guillén, C., Inoue, H., Teruyama, K., Shimizu, S., Kanno, A., García-Aguilar, A., Koike, M., et al. (2014) · Diabetes · doi:10.2337/db13-0970 · Cited by 132
“But on the other hand mTORC1 hyperactivation is also a cause of insulin resistance (1) and endoplasmic reticulum (ER) stress development (9), conditions linked with β cell dysfunction and diabetes progression (10,11).”
BackgroundInfluentialRegulation of Food Intake Through Hypothalamic Signaling Networks Involving mTOR
Woods, S. C., Seeley, R. J., & Cota, D. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155505 · Cited by 125
Insulin-Like Growth Factor 1 Physiology
Yakar, S., & Adamo, M. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.008 · Cited by 141
Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo
Lee, D. H., Shi, J., Jeoung, N. H., Kim, M. S., Zabolotny, J. M., Lee, S. W., White, M. F., Wei, L., & Kim, Y.-B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c900014200 · Cited by 125
Yamada, T., Katagiri, H., Ishigaki, Y., Ogihara, T., Imai, J., Uno, K., Hasegawa, Y., Gao, J., Ishihara, H., Niijima, A., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.001 · Cited by 134
Diurnal variation of the human adipose transcriptome and the link to metabolic disease
Loboda, A., Kraft, W. K., Fine, B., Joseph, J., Nebozhyn, M., Zhang, C., He, Y., Yang, X., Wright, C., Morris, M., et al. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-7 · Cited by 124
“Several studies have linked the AKT/PI3K/mTOR pathway to obesity and, independently, the circadian rhythm to metabolic syndrome [16, 30, 31].”
BackgroundXiao, F., Yu, J., Guo, Y., Deng, J., Li, K., Du, Y., Chen, S., Zhu, J., Sheng, H., & Guo, F. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.006 · Cited by 132
“Furthermore, mTOR activity is closely related to the ability of the cell to respond to insulin; this is underscored by the observation that increased mTOR/S6K1 signalingcontributes to thedevelopment of insulin resistance [7] and decreased mTOR/S6K1 signaling improves insulin sensitivity [24,25].”
BackgroundRapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder
Parker, W. E., Orlova, K. A., Parker, W. H., Birnbaum, J. F., Krymskaya, V. P., Goncharov, D. A., Baybis, M., Helfferich, J., Okochi, K., Strauss, K. A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005271 · Cited by 120
SIPULA, I. J., Brown, N. F., & Perdomo, G. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.002 · Cited by 126
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications
Simone, V. D., d’Avenia, M., Argentiero, A., Felici, C., Rizzo, F. M., Pergola, G. D., & Silvestris, F. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0351 · Cited by 131
mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes
Minard, A. Y., Tan, S.-X., Yang, P., Fazakerley, D. J., Domanova, W., Parker, B. L., Humphrey, S. J., Jothi, R., Stöckli, J., & James, D. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.086 · Cited by 117
“It has been suggested that hyperinsulinemia induces insulin resistance via negative feedback pathways involving phosphorylation of insulin receptor substrate (IRS) proteins (Shah and Hunter, 2006; Shah et al., 2004; Um et al., 2004).”
BackgroundInfluentialThe Role of CNS Fuel Sensing in Energy and Glucose Regulation
Cota, D., Proulx, K., & Seeley, R. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.049 · Cited by 128
mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
Goncharova, E. A., Goncharov, D. A., Li, H., Pimtong, W., Lu, S. M., Khavin, I., & Krymskaya, V. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01061-10 · Cited by 127
“Importantly, the constitutive activation of S6K1 promotes a negative-feedback loop that also inhibits phosphatidylinositol 3-kinase (PI3K) activity (37, 80, 88).”
BackgroundVergès, B. L., & Cariou, B. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.014 · Cited by 132
Miao, L., Yang, L., Huang, H., Liang, F., Ling, C., & Hu, Y. (2016) · eLife · doi:10.7554/elife.14908 · Cited by 121
“Interestingly, S6K also functions as feedback inhibition of RTK/PI3K signaling, which balances mTORC1 activation (Radimerski et al., 2002; Um et al., 2004; Yang et al., 2014).”
BackgroundDi Paolo, S., Teutonico, A., Leogrande, D., Capobianco, C., & Schena, P. F. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030196 · Cited by 120
“The model of the S6K1-deficient mouse has shown that lowering S6K1 levels potentiates insulin-induced AKT phosphorylation (39).”
BackgroundBiochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 135
“Knockout of the S6k1 gene encoding S6 kinase increases life span in female mice (Selman et al. 2009) and confers enhanced resistance to diet-induced obesity (Um et al. 2004).”
BackgroundKang, C., Lee, H., Jung, E.-S., Seyedian, R., Jo, M., Kim, J.-H., Kim, J.-S., & Kim, E. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.06.092 · Cited by 124
“In addition to the insulin signaling pathway, mammalian target of rapamycin (mTOR) was also well-known to be activated by insulin and exert the physiological feedback regulation on insulin signaling through increasing the phosphorylation of serine residue on IRS-1 (Um et al., 2004).”
Garelick, M. G., & Kennedy, B. K. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.030 · Cited by 121
“These mice have also been shown to have resistance to diet-induced obesity (Um et al., 2004), a trait associated with longevity in mice.”
Background
Metadata
- Authors
- Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., & Thomas, G.
- Affiliations
- Friedrich Miescher Institute (CH)
- Centre National de la Recherche Scientifique (FR)
- Novartis (Switzerland) (CH)
- Corresponding author
- Thomas, George
- ORCID
- Venue
- Nature
- Published
- 2004-08-11
- Volume
- 431
- Issue
- 7005
- Pages
- 200-205
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2107674876
- Cited by
- 1,677
- References
- 58
- Citations by year
- 2026: 29 · 2025: 30 · 2024: 36 · 2023: 53 · 2022: 57 · 2021: 68 · 2020: 59 · 2019: 56 · 2018: 74 · 2017: 71 · 2016: 84 · 2015: 99 · 2014: 86 · 2013: 101 · 2012: 134
- FWCI
- 25.05
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- S6K1, mTOR signaling, insulin sensitivity, insulin resistance, obesity, high-fat diet, fatty acid beta-oxidation, IRS-1 phosphorylation, beta-cell mass, impaired glucose tolerance, ob/ob mice, leptin deficiency
- MeSH terms
- Aging, Animals, Blood Glucose, Dietary Fats, Enzyme Activation, Fasting, Fatty Acids, Nonesterified, Insulin, Insulin Resistance, Lipolysis, Male, Mice, Inbred C57BL, Obesity, Oxidation-Reduction, Phosphoproteins, Phosphorylation, Receptor, Insulin, RNA, Messenger, Signal Transduction, Gene Deletion, Adipocytes, Mice, Knockout, Ribosomal Protein S6 Kinases, 70-kDa, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.